Current Operating Procedure (COP) for Bleomycin ElectroScleroTherapy (BEST) of low-flow vascular malformations
Bleomycin ElectroScleroTherapy (BEST) is a new approach in the treatment of vascular malformations. After bleomycin is administered to the malformation, electric pulses are applied to the target area to enhance the effectiveness of bleomycin. The mode of action is comparable to the effect of electro...
Saved in:
Main Authors: | Muir Tobian, Wohlgemuth Walter A, Cemazar Maja, Bertino Giulia, Groselj Ales, Ratnam Lakshmi A, McCafferty Ian, Wildgruber Moritz, Gebauer Bernhard, de Terlizzi Francesca, Zanasi Alessandro, Sersa Gregor |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2024-11-01
|
Series: | Radiology and Oncology |
Subjects: | |
Online Access: | https://doi.org/10.2478/raon-2024-0061 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hepatic and immune modulatory effectiveness of lactoferrin loaded Selenium nanoparticles on bleomycin induced hepatic injury
by: Khaled G. Abdel-Wahhab, et al.
Published: (2024-09-01) -
Bleomycin pollution and lung health: The therapeutic potential of peimine in bleomycin-induced pulmonary fibrosis by inhibiting glycolysis
by: Kangchen Li, et al.
Published: (2025-01-01) -
Inhibition of skin fibrosis via regulation of Th17/Treg imbalance in systemic sclerosis
by: Akiko Sekiguchi, et al.
Published: (2025-01-01) -
FBR2 modulates ferroptosis via the SIRT3/p53 pathway to ameliorate pulmonary fibrosis
by: Yu Cheng, et al.
Published: (2025-02-01) -
The difficult diagnosis of floor of the mouth masses: a case report
by: Alexe De Ferm, et al.
Published: (2025-01-01)